← FDA Drug Approvals (Drugs@FDA)
NAPROXEN AND ESOMEPRAZOLE MAGNESIUM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2023-10-11
Drug application
- FDA Application #
ANDA217738- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- NAPROXEN AND ESOMEPRAZOLE MAGNESIUM
- Generic name
- NAPROXEN AND ESOMEPRAZOLE MAGNESIUM
- Active ingredients
- ESOMEPRAZOLE MAGNESIUM; NAPROXEN
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- SCIEGEN PHARMS
- Manufacturer
- ScieGen Pharmaceuticals, Inc
- First approval
- 2023-10-11
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown